BridgeBio Pharma, Inc 10-K for FY2023
BridgeBio Pharma, Inc. (BBIO)
10-K
2024-02-22
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on February 22, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.3M
- down 88.0% from $77.65M a year earlier
- Net loss
- $653.25M
- compared with a net loss of $484.65M a year earlier
- Diluted EPS
- -$3.95
- compared with -$3.26 a year earlier